ID   TBC20_HUMAN             Reviewed;         403 AA.
AC   Q96BZ9; A8K6I3; B9A6M1; Q5JWQ7; Q6ZSY8; Q96NE1; Q9BYM7; Q9H140;
DT   29-AUG-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   22-JUL-2015, entry version 107.
DE   RecName: Full=TBC1 domain family member 20;
GN   Name=TBC1D20; Synonyms=C20orf140;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=19077034; DOI=10.1111/j.1365-2443.2008.01251.x;
RA   Ishibashi K., Kanno E., Itoh T., Fukuda M.;
RT   "Identification and characterization of a novel Tre-2/Bub2/Cdc16 (TBC)
RT   protein that possesses Rab3A-GAP activity.";
RL   Genes Cells 14:41-52(2009).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3).
RC   TISSUE=Brain, Lung, and Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INTERACTION WITH HCV NS5A.
RX   PubMed=17686842; DOI=10.1128/JVI.01249-07;
RA   Sklan E.H., Staschke K., Oakes T.M., Elazar M., Winters M., Aroeti B.,
RA   Danieli T., Glenn J.S.;
RT   "A Rab-GAP TBC domain protein binds hepatitis C virus NS5A and
RT   mediates viral replication.";
RL   J. Virol. 81:11096-11105(2007).
RN   [7]
RP   INVOLVEMENT IN WARBM4.
RX   PubMed=24239381; DOI=10.1016/j.ajhg.2013.10.011;
RA   Liegel R.P., Handley M.T., Ronchetti A., Brown S., Langemeyer L.,
RA   Linford A., Chang B., Morris-Rosendahl D.J., Carpanini S., Posmyk R.,
RA   Harthill V., Sheridan E., Abdel-Salam G.M., Terhal P.A., Faravelli F.,
RA   Accorsi P., Giordano L., Pinelli L., Hartmann B., Ebert A.D.,
RA   Barr F.A., Aligianis I.A., Sidjanin D.J.;
RT   "Loss-of-function mutations in TBC1D20 cause cataracts and male
RT   infertility in blind sterile mice and Warburg micro syndrome in
RT   humans.";
RL   Am. J. Hum. Genet. 93:1001-1014(2013).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 14-305 ALONE AND IN COMPLEX
RP   WITH RAB1B, AND MUTAGENESIS OF ARG-105 AND GLN-144.
RX   PubMed=23236136; DOI=10.1073/pnas.1214431110;
RA   Gavriljuk K., Gazdag E.M., Itzen A., Kotting C., Goody R.S.,
RA   Gerwert K.;
RT   "Catalytic mechanism of a mammalian Rab.RabGAP complex in atomic
RT   detail.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:21348-21353(2012).
CC   -!- FUNCTION: GTPase-activating protein specific for Rab1 and Rab2
CC       small GTPase families for which it can accelerate the intrinsic
CC       GTP hydrolysis rate by more than five orders of magnitude.
CC   -!- SUBUNIT: Directly interacts with the N-terminal amphipathic helix
CC       of hepatitis C virus (HCV) NS5A. {ECO:0000269|PubMed:17686842,
CC       ECO:0000269|PubMed:23236136}.
CC   -!- INTERACTION:
CC       P27958:- (xeno); NbExp=11; IntAct=EBI-9254454, EBI-8753518;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q96BZ9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96BZ9-2; Sequence=VSP_008100, VSP_008101, VSP_008102;
CC         Note=May be due to intron retention. No experimental
CC         confirmation available.;
CC       Name=3;
CC         IsoId=Q96BZ9-3; Sequence=VSP_031524;
CC         Note=No experimental confirmation available.;
CC   -!- DOMAIN: The arginine and glutamine fingers are critical for the
CC       GTPase-activating mechanism, they pull out Rab's 'switch 2'
CC       glutamine and insert in Rab's active site.
CC       {ECO:0000269|PubMed:23236136}.
CC   -!- DISEASE: Warburg micro syndrome 4 (WARBM4) [MIM:615663]: A form of
CC       Warburg micro syndrome, a rare syndrome characterized by
CC       microcephaly, microphthalmia, microcornia, congenital cataracts,
CC       optic atrophy, cortical dysplasia, in particular corpus callosum
CC       hypoplasia, severe mental retardation, spastic diplegia, and
CC       hypogonadism. {ECO:0000269|PubMed:24239381}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Contains 1 Rab-GAP TBC domain. {ECO:0000255|PROSITE-
CC       ProRule:PRU00163}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB449906; BAH16649.1; -; mRNA.
DR   EMBL; AK055573; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AK127062; BAC86808.1; -; mRNA.
DR   EMBL; AK291648; BAF84337.1; -; mRNA.
DR   EMBL; AL121747; CAI23015.1; -; Genomic_DNA.
DR   EMBL; AL049761; CAI23015.1; JOINED; Genomic_DNA.
DR   EMBL; AL049761; CAI23048.1; -; Genomic_DNA.
DR   EMBL; AL121747; CAI23048.1; JOINED; Genomic_DNA.
DR   EMBL; CH471133; EAX10670.1; -; Genomic_DNA.
DR   EMBL; BC014983; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS13002.1; -. [Q96BZ9-1]
DR   RefSeq; NP_653229.1; NM_144628.3. [Q96BZ9-1]
DR   RefSeq; XP_005260718.1; XM_005260661.1. [Q96BZ9-1]
DR   UniGene; Hs.590876; -.
DR   PDB; 4HL4; X-ray; 2.20 A; A=14-305.
DR   PDB; 4HLQ; X-ray; 3.30 A; A/C/E/G/I=1-305.
DR   PDBsum; 4HL4; -.
DR   PDBsum; 4HLQ; -.
DR   ProteinModelPortal; Q96BZ9; -.
DR   SMR; Q96BZ9; 25-305.
DR   BioGrid; 126139; 3.
DR   IntAct; Q96BZ9; 1.
DR   STRING; 9606.ENSP00000346139; -.
DR   PhosphoSite; Q96BZ9; -.
DR   BioMuta; TBC1D20; -.
DR   DMDM; 34395569; -.
DR   MaxQB; Q96BZ9; -.
DR   PaxDb; Q96BZ9; -.
DR   PRIDE; Q96BZ9; -.
DR   Ensembl; ENST00000354200; ENSP00000346139; ENSG00000125875.
DR   Ensembl; ENST00000461304; ENSP00000432280; ENSG00000125875.
DR   GeneID; 128637; -.
DR   KEGG; hsa:128637; -.
DR   UCSC; uc002wds.3; human. [Q96BZ9-1]
DR   CTD; 128637; -.
DR   GeneCards; GC20M000416; -.
DR   HGNC; HGNC:16133; TBC1D20.
DR   HPA; HPA043613; -.
DR   MIM; 611663; gene.
DR   MIM; 615663; phenotype.
DR   neXtProt; NX_Q96BZ9; -.
DR   Orphanet; 2510; Micro syndrome.
DR   PharmGKB; PA25683; -.
DR   eggNOG; COG5210; -.
DR   GeneTree; ENSGT00390000014944; -.
DR   HOGENOM; HOG000006927; -.
DR   HOVERGEN; HBG056376; -.
DR   InParanoid; Q96BZ9; -.
DR   OMA; FMQQAEV; -.
DR   OrthoDB; EOG7N63MJ; -.
DR   PhylomeDB; Q96BZ9; -.
DR   TreeFam; TF105942; -.
DR   ChiTaRS; TBC1D20; human.
DR   GenomeRNAi; 128637; -.
DR   NextBio; 82406; -.
DR   PRO; PR:Q96BZ9; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; Q96BZ9; -.
DR   CleanEx; HS_TBC1D20; -.
DR   Genevisible; Q96BZ9; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:AgBase.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0030173; C:integral component of Golgi membrane; IDA:UniProtKB.
DR   GO; GO:0031965; C:nuclear membrane; IDA:UniProtKB.
DR   GO; GO:0005096; F:GTPase activator activity; IDA:UniProtKB.
DR   GO; GO:0017137; F:Rab GTPase binding; IPI:UniProtKB.
DR   GO; GO:0001675; P:acrosome assembly; IEA:Ensembl.
DR   GO; GO:0090110; P:cargo loading into COPII-coated vesicle; IMP:UniProtKB.
DR   GO; GO:0006888; P:ER to Golgi vesicle-mediated transport; IMP:UniProtKB.
DR   GO; GO:0007030; P:Golgi organization; IMP:UniProtKB.
DR   GO; GO:0070309; P:lens fiber cell morphogenesis; IEA:Ensembl.
DR   GO; GO:0034389; P:lipid particle organization; IEA:Ensembl.
DR   GO; GO:0044829; P:positive regulation by host of viral genome replication; IMP:AgBase.
DR   GO; GO:0046726; P:positive regulation by virus of viral protein levels in host cell; IMP:AgBase.
DR   GO; GO:1902953; P:positive regulation of ER to Golgi vesicle-mediated transport; IMP:UniProtKB.
DR   GO; GO:0043547; P:positive regulation of GTPase activity; IMP:UniProtKB.
DR   GO; GO:0072520; P:seminiferous tubule development; IEA:Ensembl.
DR   GO; GO:0019068; P:virion assembly; IMP:UniProtKB.
DR   InterPro; IPR000195; Rab-GTPase-TBC_dom.
DR   Pfam; PF00566; RabGAP-TBC; 1.
DR   SMART; SM00164; TBC; 1.
DR   SUPFAM; SSF47923; SSF47923; 2.
DR   PROSITE; PS50086; TBC_RABGAP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome;
KW   GTPase activation; Host-virus interaction; Membrane; Polymorphism;
KW   Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN         1    403       TBC1 domain family member 20.
FT                                /FTId=PRO_0000208048.
FT   TRANSMEM    238    258       Helical. {ECO:0000255}.
FT   TRANSMEM    367    387       Helical. {ECO:0000255}.
FT   DOMAIN       60    246       Rab-GAP TBC. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00163}.
FT   SITE        105    105       Arginine finger.
FT   SITE        144    144       Glutamine finger.
FT   VAR_SEQ       1    192       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_008100.
FT   VAR_SEQ       1      1       M -> MPSGCYVPRSEPRLLPAPPPAGARVG (in
FT                                isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_031524.
FT   VAR_SEQ     209    364       SAEVGTIFALSWLITWFGHVLSDFRHVVRLYDFFLACHPLM
FT                                PIYFAAVIVLYREQEVLDCDCDMASVHHLLSQIPQDLPYET
FT                                LISRAGDLFVQFPPSELAREAAAQQQAERTAASTFKDFELA
FT                                SAQQRPDMVLRQRFRGLLRPEDRTKDVLTKPRT -> RYIC
FT                                VCISVCMHTHAHTPPHLKHSSQAERSFLIVLGGFVKFSPVV
FT                                PVTSNLGNSVLGAFLGTVLFGGHSPSLEFTSSGERWIRYVC
FT                                QGKMLRLLPQEKHKVLWDPVARRGRPTMGCFISQVPKRRNI
FT                                FLQIPCDVLFLLCLVGNVFLANASFFKIF (in isoform
FT                                2). {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_008101.
FT   VAR_SEQ     365    403       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_008102.
FT   VARIANT      79     79       N -> S (in dbSNP:rs36088178).
FT                                /FTId=VAR_052543.
FT   MUTAGEN     105    105       R->A: 1000-fold decrease in GAP activity.
FT                                {ECO:0000269|PubMed:23236136}.
FT   MUTAGEN     144    144       Q->L: 1000-fold decrease in GAP activity.
FT                                {ECO:0000269|PubMed:23236136}.
FT   CONFLICT    117    117       E -> G (in Ref. 2; BAC86808).
FT                                {ECO:0000305}.
FT   HELIX        26     40       {ECO:0000244|PDB:4HL4}.
FT   STRAND       42     44       {ECO:0000244|PDB:4HL4}.
FT   HELIX        47     55       {ECO:0000244|PDB:4HL4}.
FT   TURN         57     60       {ECO:0000244|PDB:4HLQ}.
FT   HELIX        63     73       {ECO:0000244|PDB:4HL4}.
FT   HELIX        89     92       {ECO:0000244|PDB:4HL4}.
FT   HELIX        96    104       {ECO:0000244|PDB:4HL4}.
FT   HELIX       105    109       {ECO:0000244|PDB:4HL4}.
FT   STRAND      112    114       {ECO:0000244|PDB:4HLQ}.
FT   HELIX       116    136       {ECO:0000244|PDB:4HL4}.
FT   HELIX       146    157       {ECO:0000244|PDB:4HL4}.
FT   HELIX       159    171       {ECO:0000244|PDB:4HL4}.
FT   TURN        172    175       {ECO:0000244|PDB:4HL4}.
FT   HELIX       176    178       {ECO:0000244|PDB:4HL4}.
FT   STRAND      180    182       {ECO:0000244|PDB:4HL4}.
FT   TURN        184    186       {ECO:0000244|PDB:4HL4}.
FT   HELIX       187    191       {ECO:0000244|PDB:4HL4}.
FT   HELIX       192    199       {ECO:0000244|PDB:4HL4}.
FT   HELIX       201    207       {ECO:0000244|PDB:4HL4}.
FT   HELIX       215    217       {ECO:0000244|PDB:4HL4}.
FT   HELIX       218    222       {ECO:0000244|PDB:4HL4}.
FT   TURN        223    228       {ECO:0000244|PDB:4HL4}.
FT   HELIX       232    244       {ECO:0000244|PDB:4HL4}.
FT   HELIX       249    260       {ECO:0000244|PDB:4HL4}.
FT   HELIX       262    266       {ECO:0000244|PDB:4HL4}.
FT   HELIX       274    280       {ECO:0000244|PDB:4HL4}.
FT   HELIX       288    301       {ECO:0000244|PDB:4HL4}.
SQ   SEQUENCE   403 AA;  45855 MW;  70B011A33DEF527D CRC64;
     MALRSAQGDG PTSGHWDGGA EKADFNAKRK KKVAEIHQAL NSDPTDVAAL RRMAISEGGL
     LTDEIRRKVW PKLLNVNAND PPPISGKNLR QMSKDYQQVL LDVRRSLRRF PPGMPEEQRE
     GLQEELIDII LLILERNPQL HYYQGYHDIV VTFLLVVGER LATSLVEKLS THHLRDFMDP
     TMDNTKHILN YLMPIIDQVN PELHDFMQSA EVGTIFALSW LITWFGHVLS DFRHVVRLYD
     FFLACHPLMP IYFAAVIVLY REQEVLDCDC DMASVHHLLS QIPQDLPYET LISRAGDLFV
     QFPPSELARE AAAQQQAERT AASTFKDFEL ASAQQRPDMV LRQRFRGLLR PEDRTKDVLT
     KPRTNRFVKL AVMGLTVALG AAALAVVKSA LEWAPKFQLQ LFP
//
